Consonance Capital Management LP 13D and 13G filings for Kiniksa Pharmaceuticals, Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-11-05 4:55 pm Sale | 2020-10-31 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | Consonance Capital Management LP | 1,252,229 3.990% | -988,550 (-44.12%) | Filing |